GL1X · GenesisL1 explorer

Research workbench

Structural mechanism of enzyme mistargeting in hereditary kidney stone disease in vitro

Analyse Structural mechanism of enzyme mistargeting in hereditary kidney stone disease… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1J04
Type
protein
Length
387 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Alanine--glyoxylate aminotransferase
EC
2.6.1.51, 2.6.1.44
UniProt
P21549
Ligands
AOA
Pockets
2 · best druggability 0.43

Structure

x-ray diffraction · 1 distinct chain · 41% helix, 13% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AAlanine--glyoxylate aminotransferase (EC 2.6.1.51, 2.6.1.44)protein38741% helix, 13% strandP21549

Ligands and binding sites

  • AOA · (aminooxy)acetic acid · ligand · chains A
  • GOL · Glycerol · additive · 7 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1520.430.8313empty
2810.360.7618empty

Modifications

Observed in the structure: 1 modified (cofactor).

Compared structures

  • 1J04 · Structural mechanism of enzyme mistargeting in hereditary kidney stone disease in vitro · the same entry in another collection · chain A against A, TM-score 1.00
  • P21549 · AlphaFold monomer V2.0 prediction for serine--pyruvate aminotransferase (P21549) · a predicted model of the same protein · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.